Screener
BioLife Solutions BLFS EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: BioLife Solutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:22 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054355
| (In thousands, except per share and share data) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net income (loss) per share | $0.92 | $(0.33) | $0.95 | $(0.34) |
| Net income (loss) per share - Diluted: | ||||
| Continuing operations | $0.91 | $(0.32) | $0.94 | $(0.31) |
| Discontinued operations | — | $(0.01) | — | $(0.03) |
| Net income per share | $0.91 | $(0.33) | $0.94 | $(0.34) |
| Weighted average shares used to compute income (loss) per share: | ||||
| Basic | 48,866,822 | 47,798,146 | 48,663,807 | 47,468,266 |
| Diluted | 49,294,679 | 47,798,146 | 49,259,528 | 47,468,266 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is BioLife Solutions's EPS (diluted)?
- BioLife Solutions (BLFS) reported EPS (diluted) of $0.91 in Q2 2026.
- How has BioLife Solutions's EPS (diluted) changed year-over-year?
- BioLife Solutions's EPS (diluted) increased by 375.8% year-over-year, from -$0.33 to $0.91.
- What is the long-term trend for BioLife Solutions's EPS (diluted)?
- Over 2 years (2021 to 2023), BioLife Solutions's EPS (diluted) has grown at a 154.1% compound annual growth rate (CAGR), from -$0.24 to -$1.55.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about BioLife Solutions's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude